Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos

European Journal of Nutrition

Volumn 45, Issue 6, 2006, Pages 311-319

  Padmanabhan, R ^a   Shafiullah, M ^a   Benedict, S ^a   Nagelkerke, N ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Folic acid; Homocysteine; Neural tube defects; Valproic acid; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL SPINE DISLOCATION; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; EMBRYO RESORPTION; ENVIRONMENTAL EXPOSURE; EXENCEPHALY; FETUS WEIGHT; GESTATION PERIOD; HYPERHOMOCYSTEINEMIA; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; MOUSE; NEURAL TUBE DEFECT; NONHUMAN;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FETAL GROWTH RETARDATION; FOLIC ACID; GESTATIONAL AGE; HOMOCYSTEINE; HOMOCYSTINE; MICE; NEURAL TUBE DEFECTS; PREGNANCY; RANDOM ALLOCATION; TERATOGENS; VALPROIC ACID; VITAMIN B 12;

ANIMALIA;

EID: 33748639057     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-006-0600-4     Document Type: Article

References (43)

1. Botto LD, Moore CA, Khoury MJ, Erickson JD (1999) Neural-tube defects. N Engl J Med 341:1509-15019
2. Cherian A, Seena S Bullock RK, Antony PC (2005) Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 366(9489):930-931
3. Sulik KK, Sadler TW (1993) Postulated mechanisms underlying the development of neural tube defects. Insights from in vitro and in vivo studies. Ann N Y Acad Sci 15(678):8-21
4. Frey L, Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44(Suppl 3):4-13
5. Holmes LB (1994) Spina bifida: anticonvulsants and other maternal influences. Ciba Found Symp 181:232-238
6. Robert E (1988) Valproic acid as a human teratogen. Cong Anom 28(Suppl):S71-S80
7. Lindhout D, Meinardi H, Meijer JWA, Nau H (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy, paralleled by changes in pattern of malformations. Neurology 42(suppl):94-110
8. Padmanabhan R, Ahmad I (1996) Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses. Reproduct Toxicol 10:345-363
9. Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingston S, Flanery DB, Pellock JM, Harrod MJ, Lammer EJ, Majewsky F, Schinzel A, Roriello HV, Hansen JW (1988) Verification of the fetal valproate syndrome phenotype. Am J Med Genet 29:171-185
10. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW (1981) Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 56:911-918
11. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 338(8760):131-137
12. Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New Eng J Med 327:1832-1835
13. McMullin MF, Young PB, Bailie KE, Savage GA, Lappin TR, White R (2001) Homocysteine and methylmalonic acid as indicators of folate and vitamin B12 deficiency in pregnancy. Clin Lab Haematol 23:161-165
14. Biale Y, Lewenthal H (1984) Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol 18:211-216
15. Champel V, Radal M, Moulin-Vallez M, Jonville-Bera AP, Autret-Leca E, Champel V, Radal M, Moulin-Vallez M, Jonville-Bera AP, Autret-Leca E (1999) Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy. Rev Neurol (Paris) 155:220-224
16. Heil SG, van der Put NM, Trijbels FJ, Gabreels FJ, Blom HJ (1999) Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet 7:393-396
17. Steegers-Theunissen RP, Boers GH, Blom HJ, Nijhuis JG, Thomas CM, Borm GF, Eskes TK (1995) Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172:1436-1441
18. Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Tamura T (2000) Role of amniotic fluid homocysteine level and of fetal 5, 10- methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 90(1):12-16
19. Apeland T, Mansoor MA, Strandjord RE (2001) Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res 47(1-2):27-35
20. Afman LA, Blom HJ, Van der Put NM, Van Straaten HW (2003) Homocysteine interference in neurulation: a chick embryo model. Birth Defects Res Part A Clin Mol Teratol 67:421-428
21. Epeldegui M, Pena-Melian A, Varela-Moreiras G, Perez-Miguelsanz J (2002) Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos. Teratology 65:171-179
22. Hansen DK, Grafton TF, Melnyk S, James SJ (2001) Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. Reprod Toxicol 15:239-244
23. Greene ND, Dunlevy LE, Copp AJ (2003) Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos. Anat Embryol (Berl) 206:185-191
24. Padmanabhan R, Shafiullah MM (2003) Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Cong Anom 43:29-40
25. Padmanabhan R, Ibrahim A, Bener A (2002) Effect of maternal methionine pre-treatment on alcohol-induced exencephaly and axial skeletal dysmorphogenesis in mouse fetuses. Drug Alcohol Depend 65(3):263-281
26. Commission on Life Sciences (1996) Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources National Research Council National Academy Press, Washington, D.C
27. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86(11):703-708
28. Bower C, Stanley FJ, Croft M, de Klerk N, Davis RE, Nicol DJ (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br J Nutr 69(3):827-834
29. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS (1999) The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055
30. Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, Lammer EJ, Finnell RH (2004) Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn 231(1):221-231
31. Yoo JH, Hong SB (1999) A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism 48(8):1047-1051
32. Vanaerts LA, Blom HJ, Deabreu RA, Trijbels FJ, Eskes TK, Copius Peereboom-Stegeman JH, Noordhoek J (1994) Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology 50:348-360
33. Snow MH, Tam PP (1979) Is compensatory growth a complicating factor in mouse teratology? Nature 279(5713):555-557
34. Southern F, Eidt J, Drouilhet J, Mukunyadzi P, Williams DK, Cruz C, Wang YF, Poirier LA, Brown AT, Moursi MM (2001) Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia. Atherosclerosis 158:129-138
35. Pippenger CE (2003) Pharmacology of neural tube defects. Epilepsia 44(Suppl 3):24-32
36. Carl GF (1986) Effect of chronic valproate treatment on folate-dependent methyl biosynthesis in the rat. Neurochem Res 11(5):671-85
37. Ubeda N, Alonso-Aperte E, Varela-Moreiras G (2002) Acute valproate administration impairs methionine metabolism in rats. J Nutr 132(9):2737-2742
38. Rao ML, Stefan H, Scheid C, Kuttler AD, Froscher W (1993) Serum amino acids, liver status, and antiepileptic drug therapy in epilepsy. Epilepsia 34(2):347-354
39. Heydrick SJ, Weiss N, Thomas SR, Cap AP, Pimentel DR, Loscalzo J, Keaney JF Jr (2004) l-Homocysteine and l-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med 36(5):632-640
40. Matthews RG, Sheppard C, Goulding C (1998) Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur J Pediatr 157(Suppl 2):S54-S59
41. De Franchis R, Sperandeo MP, Sebastio G, Andria G (1998) Clinical aspects of cystathionine beta-synthase deficiency: how wide is the spectrum? The Italian Collaborative Study Group on Homocystinuria. Eur J Pediatr 157(Suppl 2):S67-S70
42. Eskes TKAB (1998) Neural tube defects, vitamins and homocysteine. Eur J Pediatr 157(Suppl 2):S139-S141
43. Rosenquist TH, Schneider AM, Monogham DT (1999) N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. FASEB J 13:1523-1531